EUVIMEDEUVIMED entdecken
Open Access

LncRNA AP000695.2 promotes glycolysis of lung adenocarcinoma via the miR-335-3p/TEAD1 axis

Shuoyan Xu, Zhiming Cheng, Bulin Du, Yao Diao, Yaming Li, Xuena Li

Acta Biochimica et Biophysica Sinica · 2023

DOI: 10.3724/abbs.2023227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2023. Verfasst von Shuoyan Xu und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Lung Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AP000695.2 is a novel long non-coding RNA (lncRNA). Its aberrant high expression is remarkably associated with poor prognosis of patients with lung adenocarcinoma (LUAD). However, its role and underlying mechanism in LUAD remains unclear. Previous bioinformatics analysis indicated that AP000695.2 may be closely related to the glycolysis of LUAD. This study aims to verify and explore the mechanism of AP000695.2 in glycolysis of LUAD. Overexpression plasmid and siRNA are used to construct cell models of upregulation and downregulation of AP000695.2, respectively. AP000695.2 is highly expressed in lung cancer cell lines as revealed by qPCR. Western blot analysis, FDG uptake, lactate production assay and ECAR determination results show that high expression of AP000695.2 facilitates glycolysis of LUAD cells. CCK-8, EdU staining, Transwell and wound healing assays show that high expression of AP000695.2 promotes cell growth and migration of LUAD. The relationship between AP000695.2 and miR-335-3p is confirmed by bioinformatics analysis and dual-luciferase reporter assays. Through the dual-luciferase reporter assay, TEA domain transcription factor 1 (TEAD1) is identified as a target gene of miR-335-3p. Rescue experiments are applied to verify the relationship among AP000695.2, miR-335-3p and TEAD1. Our study indicates that AP000695.2 is involved in the mechanism of LUAD through functioning as a ceRNA to competitively sponge miR-335-3p, thereby regulating the expression of TEAD1. In the in vivo models, AP000695.2 depletion restrains tumor growth and glycolysis. AP000695.2 promotes the glycolysis of LUAD by regulating the miR-335-3p/TEAD1 axis, and it may serve as a potential target of anti-tumor energy metabolism therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsRNA, Long NoncodingLung NeoplasmsAdenocarcinomaHumansGlycolysisLungLuciferasesCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticTEA Domain Transcription Factors

Stichwörter der Autor:innen

TEAD1aerobic glycolysisceRNAlong non-coding RNA

Substanzen

MicroRNAsRNA, Long NoncodingLuciferasesTEAD1 protein, humanTEA Domain Transcription FactorsMIRN335 microRNA, human

Zitieren

APA

Xu, S., Cheng, Z., Du, B., Diao, Y., Li, Y., & Li, X. (2023). LncRNA AP000695.2 promotes glycolysis of lung adenocarcinoma via the miR-335-3p/TEAD1 axis. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2023227

Vancouver

Xu S, Cheng Z, Du B, Diao Y, Li Y, Li X. LncRNA AP000695.2 promotes glycolysis of lung adenocarcinoma via the miR-335-3p/TEAD1 axis. Acta Biochimica et Biophysica Sinica. 2023. doi:10.3724/abbs.2023227

BibTeX
@article{Xu2023,
  author = {Xu, Shuoyan and Cheng, Zhiming and Du, Bulin and Diao, Yao and Li, Yaming and Li, Xuena},
  title = {LncRNA AP000695.2 promotes glycolysis of lung adenocarcinoma via the miR-335-3p/TEAD1 axis},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2023},
  doi = {10.3724/abbs.2023227}
}
Kostenlos starten →